Early Antibody Temporal Responses to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Vaccinated Subjects Determined by the cobas 6000 Spike Assay
Arch Pathol Lab Med
.
2022 Jan 1;146(1):9-10.
doi: 10.5858/arpa.2021-0407-LE.
Authors
Hanna S Loving
1
,
Paulina Stallcup
1
,
Peter Burbelo
2
,
Jeffrey Cohen
3
,
Alan Remaley
4
,
David B Sacks
1
,
Roa Harb
1
Affiliations
1
Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland.
2
National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland.
3
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
4
National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
PMID:
34491312
PMCID:
PMC10986638
DOI:
10.5858/arpa.2021-0407-LE
No abstract available
MeSH terms
Antibodies, Viral
COVID-19*
Diagnostic Tests, Routine
Humans
SARS-CoV-2*
Substances
Antibodies, Viral
Grants and funding
Z99 CL999999/ImNIH/Intramural NIH HHS/United States